-
6P Response and survival according to the interferon-gamma (IFN-γ) signature and tumor mutational burden (tmb) in the PRADO trial testing neoadjuvant ipilimumab and nivolumab in stage III melanoma
Reijers, P. Dimitriadis, J.J. Traets, Robyn P.M. Saw, J.M. Versluis, Thomas E. Pennington, +14 more
4citations -
Integrated noninvasive diagnostics for prediction of survival in immunotherapy2024 Immuno-Oncology Technology article Medicine Radiomics and Machine Learning in Medical Imaging Open access
Melda Yeghaian, Zuhir Bodalal, Teresa M. Tareco Bucho, Ieva Kurilova, Christian U. Blank, Egbert Frederik Smit, +5 more
3citations -
119MO Phase I/II trial evaluating the innovative therapeutic cancer vaccine PDC*lung01 in combination with anti-PD-1 in patients (pts) with untreated stage IV non-small cell lung cancer2024 Immuno-Oncology Technology article Immunology and Microbiology Immunotherapy and Immune Responses Open access
J.F. Vansteenkiste, Kristof Cuppens, I. Demedts, F. Borm, B. Biesma, Maurice Pérol, +13 more
0citations -
Comprehensive analysis of the systemic immune landscape across breast cancer subtypes and disease stages2025 Immuno-Oncology Technology article Immunology and Microbiology Immune cells in cancer Open access
Noor A. M. Bakker, Veerle C. M. Geurts, Elisa Champanhet, Caroline C. W. Klaver, Maxime Duijst, Iris Nederlof, +8 more
0citations
18 results